These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36580851)

  • 1. Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex.
    Hong J; Duc NM; Jeong BC; Cho S; Shetye G; Cao J; Lee H; Jeong C; Lee H; Suh JW
    Tuberculosis (Edinb); 2023 Jan; 138():102298. PubMed ID: 36580851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions.
    Wolf NM; Lee H; Zagal D; Nam JW; Oh DC; Lee H; Suh JW; Pauli GF; Cho S; Abad-Zapatero C
    Acta Crystallogr D Struct Biol; 2020 May; 76(Pt 5):458-471. PubMed ID: 32355042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring.
    Akopian T; Kandror O; Raju RM; Unnikrishnan M; Rubin EJ; Goldberg AL
    EMBO J; 2012 Mar; 31(6):1529-41. PubMed ID: 22286948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
    Choules MP; Wolf NM; Lee H; Anderson JR; Grzelak EM; Wang Y; Ma R; Gao W; McAlpine JB; Jin YY; Cheng J; Lee H; Suh JW; Duc NM; Paik S; Choe JH; Jo EK; Chang CL; Lee JS; Jaki BU; Pauli GF; Franzblau SG; Cho S
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the interactions between Mycobacterium tuberculosis caseinolytic protease C1 (ClpC1) and ecumicin.
    Jung IP; Ha NR; Kim AR; Kim SH; Yoon MY
    Int J Biol Macromol; 2017 Aug; 101():348-357. PubMed ID: 28342755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1.
    Leodolter J; Warweg J; Weber-Ban E
    PLoS One; 2015; 10(5):e0125345. PubMed ID: 25933022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives.
    Greve J; Mogk A; Kazmaier U
    Mar Drugs; 2022 Oct; 20(10):. PubMed ID: 36286456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and proteolytic processing of mycobacterial ClpP1 and ClpP2.
    Benaroudj N; Raynal B; Miot M; Ortiz-Lombardia M
    BMC Biochem; 2011 Dec; 12():61. PubMed ID: 22132756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unfoldase ClpC1 of
    Lunge A; Gupta R; Choudhary E; Agarwal N
    J Biol Chem; 2020 Jul; 295(28):9455-9473. PubMed ID: 32409584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.
    Wolf NM; Lee H; Choules MP; Pauli GF; Phansalkar R; Anderson JR; Gao W; Ren J; Santarsiero BD; Lee H; Cheng J; Jin YY; Ho NA; Duc NM; Suh JW; Abad-Zapatero C; Cho S
    ACS Infect Dis; 2019 Jun; 5(6):829-840. PubMed ID: 30990022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide Lassomycin.
    Jagdev MK; Tompa DR; Ling LL; Peoples AJ; Dandapat J; Mohapatra C; Lewis K; Vasudevan D
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126771. PubMed ID: 37683752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.
    Gao W; Kim JY; Anderson JR; Akopian T; Hong S; Jin YY; Kandror O; Kim JW; Lee IA; Lee SY; McAlpine JB; Mulugeta S; Sunoqrot S; Wang Y; Yang SH; Yoon TM; Goldberg AL; Pauli GF; Suh JW; Franzblau SG; Cho S
    Antimicrob Agents Chemother; 2015 Feb; 59(2):880-9. PubMed ID: 25421483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of action.
    Weinhäupl K; Gragera M; Bueno-Carrasco MT; Arranz R; Krandor O; Akopian T; Soares R; Rubin E; Felix J; Fraga H
    J Biol Chem; 2022 Nov; 298(11):102553. PubMed ID: 36208775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit different substrate specificities.
    Personne Y; Brown AC; Schuessler DL; Parish T
    PLoS One; 2013; 8(4):e60228. PubMed ID: 23560081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rufomycin Exhibits Dual Effects Against
    Park CR; Paik S; Kim YJ; Kim JK; Jeon SM; Lee SH; Whang J; Cheng J; Suh JW; Cao J; Shetye G; Chen SN; McAlpine J; Pauli GF; Franzblau S; Cho S; Jo EK
    Front Microbiol; 2021; 12():695024. PubMed ID: 34447358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.
    Li M; Kandror O; Akopian T; Dharkar P; Wlodawer A; Maurizi MR; Goldberg AL
    J Biol Chem; 2016 Apr; 291(14):7465-76. PubMed ID: 26858247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The essential
    d'Andrea FB; Poulton NC; Froom R; Tam K; Campbell EA; Rock JM
    Sci Adv; 2022 May; 8(18):eabn7943. PubMed ID: 35507665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ClgR, a novel regulator of clp and lon expression in Streptomyces.
    Bellier A; Mazodier P
    J Bacteriol; 2004 May; 186(10):3238-48. PubMed ID: 15126487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct clpP genes control specific adaptive responses in Bacillus thuringiensis.
    Fedhila S; Msadek T; Nel P; Lereclus D
    J Bacteriol; 2002 Oct; 184(20):5554-62. PubMed ID: 12270812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection.
    Raju RM; Unnikrishnan M; Rubin DH; Krishnamoorthy V; Kandror O; Akopian TN; Goldberg AL; Rubin EJ
    PLoS Pathog; 2012 Feb; 8(2):e1002511. PubMed ID: 22359499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.